BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3569025)

  • 1. Phenytoin and phenobarbital protein binding alterations in a uremic burn patient.
    Pugh CB
    Drug Intell Clin Pharm; 1987 Mar; 21(3):264-7. PubMed ID: 3569025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temperature dependence of phenytoin-protein binding in serum: effects of uremia and hypoalbuminemia.
    Allison TB; Comstock TJ
    Ther Drug Monit; 1988; 10(4):376-81. PubMed ID: 3201522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated free fosphenytoin concentrations in uremic sera: uremic toxins hippuric acid and indoxyl sulfate do not account for the impaired protein binding of fosphenytoin.
    Dasgupta A; Havlik D
    Ther Drug Monit; 1998 Dec; 20(6):658-62. PubMed ID: 9853983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microdialysis sampling of carbamazepine, phenytoin and phenobarbital in subcutaneous extracellular fluid and subdural cerebrospinal fluid in humans: an in vitro and in vivo study of adsorption to the sampling device.
    Lindberger M; Tomson T; Lars S
    Pharmacol Toxicol; 2002 Oct; 91(4):158-65. PubMed ID: 12530465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenytoin-oxacillin interactions in normal and uremic sera.
    Dasgupta A; Sperelakis A; Mason A; Dean R
    Pharmacotherapy; 1997; 17(2):375-8. PubMed ID: 9085332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous phenytoin and phenobarbital: anticonvulsant action, brain content, and plasma binding in rat.
    Leppik IE; Sherwin AL
    Epilepsia; 1979 Jun; 20(3):201-7. PubMed ID: 446431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative binding of acetaminophen, lidocaine, phenobarbital, phenytoin, quinidine, and theophylline to human tissues in vitro.
    Bailey DN
    J Anal Toxicol; 1997; 21(1):1-4. PubMed ID: 9013284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of equilibrium dialysis, ultrafiltration, and gel permeation chromatography for the determination of free fractions of phenobarbital and phenytoin.
    Melten JW; Wittebrood AJ; Willems HJ; Faber GH; Wemer J; Faber DB
    J Pharm Sci; 1985 Jun; 74(6):692-4. PubMed ID: 4020659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of inhibitors of ligand: albumin-binding from uremic body fluids and normal urine.
    Gulyassy PF; Bottini AT; Jarrard EA; Stanfel LA
    Kidney Int Suppl; 1983 Dec; 16():S238-42. PubMed ID: 6588258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro displacement of phenytoin from protein binding by nonsteroidal antiinflammatory drugs tolmetin, ibuprofen, and naproxen in normal and uremic sera.
    Dasgupta A; Timmerman TG
    Ther Drug Monit; 1996 Feb; 18(1):97-9. PubMed ID: 8848829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine and phenytoin binding to plasma proteins in renal and hepatic failure.
    Olsen GD; Bennett WM; Porter GA
    Clin Pharmacol Ther; 1975 Jun; 17(6):677-84. PubMed ID: 1095281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in drug metabolism with increasing age: 2. phenytoin clearance and protein binding.
    Hayes MJ; Langman MJ; Short AH
    Br J Clin Pharmacol; 1975 Feb; 2(1):73-9. PubMed ID: 1234490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A major inhibitor of phenytoin binding to serum protein in uremia.
    Mabuchi H; Nakahashi H
    Nephron; 1988; 48(4):310-4. PubMed ID: 3362278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diphenylhydantoin metabolism in uremia.
    Letteri JM; Mellk H; Louis S; Kutt H; Durante P; Glazko A
    N Engl J Med; 1971 Sep; 285(12):648-52. PubMed ID: 5563477
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the serum protein binding of maprotiline and phenytoin in uraemic patients on haemodialysis.
    Lynn K; Braithwaite R; Dawling S; Rosser R
    Eur J Clin Pharmacol; 1981 Jan; 19(1):73-7. PubMed ID: 7461027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug metabolism in uremia.
    Reidenberg MM
    Clin Nephrol; 1975; 4(3):83-5. PubMed ID: 1102176
    [No Abstract]   [Full Text] [Related]  

  • 17. Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding.
    Odar-Cederlöf I; Borgå O
    Eur J Clin Pharmacol; 1974; 7(1):31-7. PubMed ID: 4852619
    [No Abstract]   [Full Text] [Related]  

  • 18. Prediction of free phenytoin levels based on [total phenytoin]/[albumin] ratios. Potential errors with hypoalbuminemia.
    Dasgupta A; Dennen DA; Dean R; McLawhon RW
    Am J Clin Pathol; 1991 Feb; 95(2):253-6. PubMed ID: 1992618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid.
    Odar-Cederlöf I; Borga O
    Clin Pharmacol Ther; 1976 Jul; 20(1):36-47. PubMed ID: 1277724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma protein binding of phenytoin in health and disease: relevance to therapeutic drug monitoring.
    Perucca E
    Ther Drug Monit; 1980; 2(4):331-44. PubMed ID: 7013166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.